Literature DB >> 6383071

The human sympathochromaffin system.

S D Shah, T F Tse, W E Clutter, P E Cryer.   

Abstract

Hypoglycemia stimulates adrenomedullary epinephrine secretion; standing stimulates sympathetic neural norepinephrine release. In five bilaterally adrenalectomized persons plasma epinephrine, measured with a sensitive single-isotope derivative assay, rose from 15 +/- 2 to 35 +/- 7 pg/ml (P less than 0.02) during hypoglycemia but did not increase during standing. In contrast, plasma norepinephrine rose during standing but not during hypoglycemia. Thus, in humans 1) extra-adrenal epinephrine secretion is regulated and derived from innervated cells other than sympathetic postganglionic neurons; 2) because the plasma levels of epinephrine in adrenalectomized individuals even in response to the potent stimulus of hypoglycemia are below physiological thresholds, any biological actions of extra-adrenal epinephrine in adults must be paracrine rather than endocrine in nature; 3) hypoglycemia does not appear to stimulate the sympathetic nervous system. In view of these findings, we propose that extra-CNS catecholamine-producing tissues be termed the sympathochromaffin system consisting of two components: 1) the sympathetic nervous system that releases the neurotransmitter norepinephrine from its postganglionic neurons, and 2) the chromaffin tissues, including the adrenal medullae, that contain cells that secrete epinephrine, norepinephrine, or dopamine. The plasma epinephrine concentration is a valid measure of its chromaffin tissue (predominantly adrenomedullary) secretion, whereas the plasma norepinephrine concentration is an index of sympathetic neuronal activity under some but not all conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383071     DOI: 10.1152/ajpendo.1984.247.3.E380

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Adrenal responses to stress.

Authors:  David S Goldstein
Journal:  Cell Mol Neurobiol       Date:  2010-11       Impact factor: 5.046

Review 2.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

Review 3.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

4.  Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans.

Authors:  K Howlett; H Galbo; J Lorentsen; R Bergeron; T Zimmerman-Belsing; J Bülow; U Feldt-Rasmussen; M Kjaer
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

5.  An intrinsic cardiac adrenergic system can regulate cardiac development and function.

Authors:  F M Abboud
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 6.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

7.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Authors:  N S Schwartz; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  Skin nerve sympathetic activity during insulin-induced hypoglycaemia.

Authors:  C Berne; J Fagius
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

9.  The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

10.  Conditional mutagenesis of Gata6 in SF1-positive cells causes gonadal-like differentiation in the adrenal cortex of mice.

Authors:  Marjut Pihlajoki; Elisabeth Gretzinger; Rebecca Cochran; Antti Kyrönlahti; Anja Schrade; Theresa Hiller; Laura Sullivan; Michael Shoykhet; Erica L Schoeller; Michael D Brooks; Markku Heikinheimo; David B Wilson
Journal:  Endocrinology       Date:  2013-03-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.